Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1CNS 1

Conditions

Sarcoma 436Osteosarcoma 134Sarcoma, Ewing 89Melanoma 81Rhabdomyosarcoma 78Neoplasms 71Gastrointestinal Stromal Tumors 63Neuroblastoma 62Bone Neoplasms 62Colorectal Neoplasms 61Breast Neoplasms 60Ovarian Neoplasms 58Glioblastoma 55Neoplasm Metastasis 52Liposarcoma 50Dendritic Cell Sarcoma, Interdigitating 45Carcinoma, Non-Small-Cell Lung 44Leiomyosarcoma 43Gliosarcoma 42Stomach Neoplasms 41Pancreatic Neoplasms 41Lymphoma 37Sarcoma, Synovial 35Glioma 35Carcinoma, Renal Cell 35Uterine Cervical Neoplasms 34Rhabdoid Tumor 34Neurofibrosarcoma 34Lung Neoplasms 34Sarcoma, Kaposi 33

Interventions

tazemetostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Inhibition, Psychological × Sarcoma × 1 year × Clear all
NCT04917042 2026-06-04

Tazemetostat in Malignant Peripheral Nerve Sheath Tumors

University of Florida

Phase 2 Active not recruiting
10 enrolled 12 charts
Sarcoma

Inhibition, Psychological, Sarcoma, Nerve Sheath Neoplasms, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡